当前位置: 首页 > 期刊 > 《医学美学美容》 > 2024年第13期
编号:2154628
贝复济在颜面再发性皮炎患者中的应用价值
http://www.100md.com 2024年7月29日 医学美学美容 2024年第13期
1资料与方法,2结果,3讨论,参考文献
     [摘 要]目的 探究贝复济在治疗颜面再发性皮炎中的效果。方法 选取2021年4月-2024年3月于我院进行治疗的80例颜面再发性皮炎患者作为研究对象,随机分为参照组与试验组,各40例。参照组口服枸地氯雷他定片,并配合维C冷喷治疗,试验组在此基础上加用贝复济治疗,比较两组主、客观症状积分以及临床疗效。结果 试验组主、客观症状积分分别为(0.43±0.09)分与(0.32±0.06)分,低于参照组的(2.90±0.19)分与(2.20±0.18)分,差异有统计学意义(P<0.05);试验组治疗总有效率为100.00%,高于参照组的70.00%,差异有统计学意义(P<0.05)。结论 贝复济治疗颜面再发性皮炎疗效确切,可有效改善患者面部症状,提高患者治疗总有效率,值得应用。

    [关键词] 贝复济;颜面再发性皮炎;皮肤屏障功能

    [中图分类号] R758.2 [文献标识码] A [文章编号] 1004-4949(2024)13-0082-04

    Application Value of Beifuji in Patients with Facial Recurrent Dermatitis

    PU Zhen, ZHOU Ai-zhen, LI Yin-ling, CHEN Jie-wei

    (Department of Dermatology, the Fourth People’s Hospital of Taizhou, Taizhou 225300, Jiangsu, China)

    [Abstract]Objective To explore the effect of Beifuji in the treatment of facial recurrent dermatitis. Methods A total of 80 patients with facial recurrent dermatitis who were treated in our hospital from April 2021 to March 2024 were randomly divided into reference group and experimental group, with 40 patients in each group. The reference group was treated with oral desloratadine citrate disodium tablets and combined with vitamin C cold spray. The experimental group was treated with beifuji on this basis. The subjective and objective symptom scores and clinical efficacy of the two groups were compared. Results The subjective and objective symptom scores of the experimental group were (0.43±0.09)scores and (0.32±0.06)scores ......

您现在查看是摘要页,全文长 11209 字符